Plant Health Care plc
("Plant Health Care" or "the Company")
Director Dealings / PDMR Shareholding
Plant Health Care, a leading provider of novel patent-protected biological products to global agricultural markets, has been informed that on 27 May 2022, Dr Christopher Richards, Chief Executive Officer of the Company, purchased 610,000 ordinary shares of 1.0 pence each in the capital of the Company ("Ordinary Shares") at a price of 12.34 pence per Ordinary Share. The purchase was to make good his holding following the inadvertent sale made in error by the administrator of Dr Richards's SIPP account, which was announced on 21 April 2022, and, at which time, Dr Richards confirmed his intention to rectify his position when he was able to do so.
Following this purchase, Dr Richards and persons closely associated with him are beneficially interested in 4,285,527 Ordinary Shares, representing approximately 1.4% of the Company's issued share capital.
Enquiries
| Plant Health Care plc | +1 919 926 1600 |
| Richard Webb - Chairman | |
| | |
| Cenkos Securities plc - Nomad & Broker Neil McDonald / Peter Lynch | +44 (0) 20 7391 8900 |
Company website: www.planthealthcare.com
The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||
| a) | Name | Dr Christopher Richards | ||||||||
| 2 | Reason for the notification | |||||||||
| a) | Position/status | Chief Executive Officer | ||||||||
| b) | Initial notification/Amendment | Initial notification | ||||||||
| 3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
| a) | Name | Plant Health Care plc | ||||||||
| b) | LEI |
213800KBQPJZ2FM8QH27
| ||||||||
| 4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
| a) | Description of the financial instrument, type of instrument
Identification code | Ordinary Shares of 1p each | ||||||||
| b) | Nature of the transaction | Purchase of Shares | ||||||||
| c) | Price(s) and volume(s) |
| ||||||||
| d) | Aggregated information
|
N/A
| ||||||||
| e) | Date of the transaction | 27.05.2022 | ||||||||
| f) | Place of the transaction | AIM, London Stock Exchange | ||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
